Eastman Chemical (EMN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Zacks
Eastman Chemical (EMN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended December 2025, Eastman Chemical (EMN) reported revenue of $1.97 billion, down 12.1% over the same period last year. EPS came in at $0.75, compared to $1.87 in the year-ago quarter.

The reported revenue represents a surprise of -3.15% over the Zacks Consensus Estimate of $2.04 billion. With the consensus EPS estimate being $0.76, the EPS surprise was -1.68%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Eastman Chemical performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Net Sales- Chemical Intermediates: $418 million compared to the $445.28 million average estimate based on four analysts. The reported number represents a change of -16.9% year over year. Net Sales- Fibers: $234 million versus the four-analyst average estimate of $244.64 million. The reported number represents a year-over-year change of -27.1%. Net Sales- Advanced Materials: $656 million versus $677.13 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -8.9% change. Net Sales- Additives & Functional Products: $662 million versus $668.41 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -4.9% change. Net Sales- Other: $3 million versus $5 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -40% change. Adjusted EBIT- Additives & Functional Products: $94 million compared to the $88.79 million average estimate based on four analysts. Adjusted EBIT- Advanced Materials: $59 million versus $46.76 million estimated by four analysts on average. Adjusted EBIT- Chemical Intermediates: $-28 million versus $-4.29 million estimated by four analysts on average. Adjusted EBIT- Other: $-40 million versus $-37.75 million estimated by four analysts on average. Adjusted EBIT- Fibers: $49 million versus $62.33 million estimated by four analysts on average.

View all Key Company Metrics for Eastman Chemical here>>>

Shares of Eastman Chemical have returned +8.2% over the past month versus the Zacks S&P 500 composite's +0.8% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Beyond Nvidia: AI's Second Wave Is Here

The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. Little-known AI firms tackling the world's biggest problems may be more lucrative in the coming months and years.

See

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Eastman Chemical Company (EMN): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Other news